CD33 is thought to act in the opposite direction to TREM2, as it can reduce Aβ phagocytosis and increase the risk of AD (Bradshaw et al., 2013; Griciuc et al., 2013; Yin et al., 2017). The gene discussed is CD33; the disease is Alzheimer disease.